Delivery Order SPE2DB20D1004-SPE2DB23FG4X6

Award Date 9/1/23
Potential Completion Date 9/5/23
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 1,000 units of the pharmaceutical product Montelukast Sodium 10 mg Tablets. The $1,425.54 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with a completion date of November 9, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Montelukast Sodium 4 mg Chewable Tablets. The contract has a firm fixed price of $1,537.31 and an ultimate completion date of January 24, 2025. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. The contract is issued under a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,054.96 firm fixed-price contract is for the delivery of Montelukast Sodium 4 mg granules, a medication used to treat asthma and allergies. The contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,127.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Cetirizine HCL 5 mg tablets in 100-count bottles, with a completion date of May 6, 2024. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and expiring in November 2026. The IDC serves as the...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $179,780 delivery order by the Defense Logistics Agency to supply 90 boxes of montelukast sodium 4 mg chewable tablets. The order is to be fulfilled by September 25, 2023, with performance taking place in Conshohocken, Pennsylvania under firm fixed pricing terms. No set aside designation or subcontracting details were provided. This order is likely placed against DLA's Pharmaceutical Prime...
The Defense Logistics Agency awarded a $363,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 boxes of montelukast sodium 10 mg tablets. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one day period in August 2023. No set aside designation or subcontractors were identified. This order supports...
This federal contract award, valued at $2,421.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,803,656 units of Cetirizine HCL 5 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC enables Cencora, Inc. to efficiently deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,301.62, is for the delivery of Cetirizine-PSE ER 5-120 mg tablets over a 1-year period ending on December 5, 2023. The award is not designated as a set-aside and was made through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,772.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of pharmaceutical products, including a specific medical inhaler, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FS31P, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,407.16 firm fixed-price delivery order is for the supply of 4,563,489,694 units of Cetirizine HCL 10 MG Tablets, a pharmaceutical product. This award is not associated with a set-aside program. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG4X6
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Montelukast Sodium 5 mg Chewable Tablets in 50-count units. The $1,744.90 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of September 5, 2023.

The contract is not designated as a set-aside award. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to support military healthcare programs globally. Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.

Generated 2/27/25, 1:33 PM